571 related articles for article (PubMed ID: 12527707)
1. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
Melendez ND; Smoller BR; Morgan M
Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
Ho T; Horn T; Finzi E
Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
4. Expression of adhesion receptors in epidermal tumors: correlation with TNF alpha expressing cells.
Viac J; Schmitt D; Claudy A
Anticancer Res; 1995; 15(2):551-5. PubMed ID: 7539238
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma.
Basta-Juzbasić A; Klenkar S; Jakić-Razumović J; Pasić A; Loncarić D
Acta Dermatovenerol Croat; 2004; 12(4):251-6. PubMed ID: 15588557
[TBL] [Abstract][Full Text] [Related]
6. Expression of ICAM-1, VCAM-1, and LFA-1 in adenocarcinoma of the lung with observations on the expression of these adhesion molecules in non-neoplastic lung tissue.
Jiang Z; Woda BA; Savas L; Fraire AE
Mod Pathol; 1998 Dec; 11(12):1189-92. PubMed ID: 9872650
[TBL] [Abstract][Full Text] [Related]
7. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of desmosomal glycoproteins in keratoacanthoma and squamous cell carcinoma of the skin: an immunohistochemical aid to diagnosis.
Krunic AL; Garrod DR; Smith NP; Orchard GS; Cvijetic OB
Acta Derm Venereol; 1996 Sep; 76(5):394-8. PubMed ID: 8891017
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
Fernandez-Flores A
Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
[No Abstract] [Full Text] [Related]
10. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma.
Beham A; Regauer S; Soyer HP; Beham-Schmid C
Adv Anat Pathol; 1998 Sep; 5(5):269-80. PubMed ID: 10021894
[TBL] [Abstract][Full Text] [Related]
11. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
Ribeiro D; Narikawa S; Marques ME
Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
[TBL] [Abstract][Full Text] [Related]
12. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
Kossard S; Tan KB; Choy C
Am J Dermatopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18360115
[TBL] [Abstract][Full Text] [Related]
13. Adhesion molecule expression in basal cell carcinoma.
Verhaegh M; Beljaards R; Veraart J; Hoekzema R; Neumann M
Eur J Dermatol; 1998 Jun; 8(4):252-5. PubMed ID: 9649678
[TBL] [Abstract][Full Text] [Related]
14. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas.
Chen-Tsai CP; Colome-Grimmer M; Wagner RF
Dermatol Surg; 2004 Jul; 30(7):1009-16. PubMed ID: 15209791
[TBL] [Abstract][Full Text] [Related]
15. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
[TBL] [Abstract][Full Text] [Related]
16. Filaggrin distribution in keratoacanthomas and squamous cell carcinoma.
Klein-Szanto AJ; Barr RJ; Reiners JJ; Mamrack MD
Arch Pathol Lab Med; 1984 Nov; 108(11):888-90. PubMed ID: 6385922
[TBL] [Abstract][Full Text] [Related]
17. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies.
Perabo F; Sharma S; Gierer R; Wirger A; Fimmers R; Steiner G; Adam M; Schultze-Seemann W
Indian J Cancer; 2001 Mar; 38(1):1-7. PubMed ID: 14758878
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular cell adhesion molecule-1 (CD 106) in normal and neoplastic human esophageal squamous epithelium.
Heidemann J; Maaser C; Lügering A; Spahn TW; Zimmer KP; Herbst H; Rafiee P; Domschke W; Krieglstein CF; Binion DG; Kucharzik TF
Int J Oncol; 2006 Jan; 28(1):77-85. PubMed ID: 16327982
[TBL] [Abstract][Full Text] [Related]
19. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
20. Subungual keratoacanthoma: a variant of verrucous squamous cell carcinoma of the skin.
Scarani P; Ghigi G; Bertarelli C; Eusebi V
Appl Pathol; 1983; 1(6):339-42. PubMed ID: 6679793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
